Aurantiamide acetate (TMC-58A) is a selective and orally active cathepsininhibitor isolated from Portulaca oleracea L. Aurantiamide acetate has anti-inflammatory activities and can be used for the study ofinflammatory diseases.
性状
Solid
IC50 & Target[1][2]
cathepsin L
体外研究(In Vitro)
Aurantiamide acetate inhibits cathepsin L (3.4.22.15) and cathepsin B (3.4.22.1) with IC50 of 12 μM and 49 μM, respectiveiy.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.